GEISINGER BLOOMSBURG HOSPITAL — History
CCN 390003 | 3-year financial timeline | COVID resilience: 97/100
🛡️ Public data only — no PHI permitted on this instance.
$75M
Latest Revenue (FY2022)
+15.2%
Revenue CAGR (3yr)
6.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $57M | $71M | $75M | +6.8% | +15.2% |
| Operating Expenses | $59M | $69M | $70M | +2.0% | +9.6% |
| Operating Margin | -3.4% | 2.0% | 6.5% | +218.0% | +0.0% |
| Net Income | $-2M | $1M | $5M | +239.6% | +0.0% |
| Licensed Beds | 33 | 30 | 40 | +33.3% | +10.1% |
| Total Patient Days | 6,552 | 8,165 | 7,372 | -9.7% | +6.1% |
| Medicare Day % | 24% | 28% | 25% | -8.1% | +3.0% |
| Medicaid Day % | 14% | 2% | 2% | +27.5% | -61.5% |
COVID Impact & Recovery
Resilience Score: 97/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +32.8% ($57M → $75M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+15.2%
This Hospital
+7.6%
State Avg
Latest Margin
6.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $85M | 11.4% |
| FY2024 (proj) | $94M | 16.3% |
| FY2025 (proj) | $103M | 21.2% |